Frontiers in Immunology

Original Research

Published on 06 Feb 2025

BAFF and APRIL immunotherapy following Bacille Calmette-Guérin vaccination enhances protection against pulmonary tuberculosis in mice

in Vaccines and Molecular Therapeutics

Min Xie
Chen-Yu Tsai
Joshua Woo
Frank Nuritdinov
Melissa Cristaldo
Narineh M. Odjourian
Rosleine Antilus-Sainte
Maureen Dougher
Martin Gengenbacher

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551183

2,357 views
2 citations

Review

Published on 06 Feb 2025

Current status of cytokine-induced killer cells and combination regimens in breast cancer

in Cancer Immunity and Immunotherapy

Yuancong Jiang
Jie Qiu
Nanwei Ye
Yingchun Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1476644

1,998 views
2 citations

Original Research

Published on 06 Feb 2025

Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Dana Emerson
Eve Merriman
Pia P. Yachi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1534462

2,969 views

Original Research

Published on 06 Feb 2025

The AMD-associated genetic polymorphism CFH Y402H confers vulnerability to Hydroquinone-induced stress in iPSC-RPE cells

in Molecular Innate Immunity

Angela Armento
Inga Sonntag
Ana-Cristina Almansa-Garcia
Merve Sen
Sylvia Bolz
Blanca Arango-Gonzalez
Ellen Kilger
Ruchi Sharma
Kapil Bharti
Rosario Fernandez-Godino

Frontiers in Immunology

doi 10.3389/fimmu.2025.1527018

3,655 views
1 citation

Review

Published on 06 Feb 2025

KLF4: a multifunctional nexus connecting tumor progression and immune regulation

in Cancer Immunity and Immunotherapy

Yunjie Ju
Wen Xiao
Bryan James Mathis
Ying Shi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514780

3,317 views
2 citations

Original Research

Published on 06 Feb 2025

Heterogeneity in polyamine metabolism dictates prognosis and immune checkpoint blockade response in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Jianyan Pan
Zhong Lin
Qinchun Pan
Tao Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516332

1,950 views

Case Report

Published on 06 Feb 2025

Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

David Qixiang Chen
José Adalberto Inzunza Domínguez
Juan Manuel Valle Uzeta
Abhiram P. Pushparaj
Jonathan E. Dickinson

Frontiers in Immunology

doi 10.3389/fimmu.2025.1535782

14,669 views
1 citation

Case Report

Published on 06 Feb 2025

Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Jingliang Zhang
Minzhe Hu
Chunjuan Wang
Shougang Guo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1509143

3,818 views

Original Research

Published on 06 Feb 2025

An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers

in Cancer Immunity and Immunotherapy

Ruyi Liu
Yuchen Liu
Weicheng Huang
Pengxiang Chen
Yufeng Cheng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1477913

2,899 views

Original Research

Published on 06 Feb 2025

Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers

in Multiple Sclerosis and Neuroimmunology

Xin Wang
Ruibin Zhao
Jiayu Fan
Chong Liu
Li Zhang
Huafang Yang
Weiyi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1534172

1,644 views

Original Research

Published on 06 Feb 2025

Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers

in Cytokines and Soluble Mediators in Immunity

Binhao Liu
Jiacheng Shen
Jiayu Li
Bowen Tian
Bin Zhou
Jiachen Gui
Zhimin Li
Yue Zhang
Wenzhi Hu
Qiang Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1468665

2,692 views
1 citation

Original Research

Published on 06 Feb 2025

HPK1 kinase inhibitor: a sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders

in Cancer Immunity and Immunotherapy

Qin Wang
Xinyi Zhu
Jing Li
Sanjia Xu
Ali Wang
Xinwen Zhang
Xingxing Wang
Xiaopeng Cai
Haimei Xing
Ye Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1449106

3,800 views
2 citations

Original Research

Published on 06 Feb 2025

Evaluation of the immunological functions of placental alkaline phosphatase in vivo using ALPP transgenic mice

in Immunological Tolerance and Regulation

Tse-Ching Chen
Kwai-Fong Ng
Ning Chen
Yi-Ling Pan
Chun-An Cheng
Hsiao-Chun Wu
Yi-Jen Hsueh
Nien-Yi Chiang
Hsi-Hsien Lin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1499388

1,962 views

Original Research

Published on 06 Feb 2025

Ddx21 mutant peptide is an effective neoantigen in prophylactic lung cancer vaccines and activates long-term anti-tumor immunity

in Cancer Immunity and Immunotherapy

Zhe Zhang
Yimeng Xia
Zhihong Wang
Yaxing Sun
Dan Pu
Yijia He
Ruixian Liu
Yanru Zhang
Yan Liu
Junzhi Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1500417

2,064 views

Hypothesis and Theory

Published on 06 Feb 2025

Microbes, macrophages, and melanin: a unifying theory of disease as exemplified by cancer

in Cancer Immunity and Immunotherapy

Stacie Z. Berg
Jonathan Berg

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493978

3,751 views

Original Research

Published on 06 Feb 2025

Detection of chimeric alpha-defensin transcripts and peptides in mouse Paneth cells

in Mucosal Immunity

Steven Timmermans
Charlotte Wallaeys
Somara De Beul
Natalia Garcia-Gonzales
Claude Libert

Frontiers in Immunology

doi 10.3389/fimmu.2025.1543059

1,716 views
1 citation